MapLight Therapeutics, Inc. (MPLT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 162K | 140K | 136K | 136K | 166K | 0 | 147K | 128K |
| COGS % of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | -162K | -140K | -136K | -136K | -166K | 0 | -147K | -128K |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 2.41% | - | - | - | -12.93% | - | -14.84% | - |
| Operating Expenses | 64.34M | 83.24M | 31.5M | 30.53M | 23.38M | 22.78M | 19.14M | 12.04M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 10.66M | 18.75M | 4.4M | 3.82M | 3.76M | 2.06M | 3.94M | 1.62M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - |
| Research & Development | 53.68M | 64.48M | 27.09M | 26.71M | 19.62M | 20.71M | 15.2M | 10.42M |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -64.5M | -83.38M | -31.5M | -30.66M | -23.54M | -22.78M | -19.29M | -12.16M |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -173.99% | -266.06% | - | - | -22.04% | - | -58.58% | - |
| EBITDA | -64.34M | -83.24M | -31.36M | -30.53M | -23.38M | -22.58M | -19.14M | -12.04M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -175.24% | -268.58% | - | - | -22.11% | - | -59.04% | - |
| D&A (Non-Cash Add-back) | 162K | 140K | 136K | 136K | 166K | 194K | 147K | 128K |
| EBIT | -60.67M | -79.55M | -29.42M | -29.85M | -22.34M | -21.23M | -18.93M | -11.98M |
| Net Interest Income | 2.47M | 2.47M | 1.55M | 688K | 811K | 899K | 890K | 184K |
| Interest Income | 2.47M | 2.47M | 1.55M | 688K | 811K | 899K | 890K | 184K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.83M | 3.83M | 2.08M | 818K | 1.2M | 1.55M | 356K | 184K |
| Pretax Income | -60.67M | -79.55M | -29.42M | -29.85M | -22.34M | -21.23M | -18.93M | -11.98M |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -60.67M | -79.55M | -29.42M | -29.85M | -22.34M | -21.23M | -18.93M | -11.98M |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | -171.58% | -274.71% | - | - | -17.98% | - | -58.04% | - |
| Net Income (Continuing) | -60.67M | -79.55M | -29.42M | -29.85M | -22.34M | -21.23M | -18.93M | -11.98M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.34 | -1.81 | -0.71 | -0.72 | -0.54 | -0.51 | -0.46 | -0.29 |
| EPS Growth % | -148.15% | -254.9% | - | - | -17.39% | - | -58.62% | - |
| EPS (Basic) | -1.34 | -1.81 | -0.71 | -0.72 | -0.54 | -0.51 | -0.46 | -0.29 |
| Diluted Shares Outstanding | 45.28M | 44.02M | 41.43M | 41.43M | 41.43M | 41.43M | 41.43M | 41.43M |
| Basic Shares Outstanding | 45.28M | 44.02M | 41.43M | 41.43M | 41.43M | 41.43M | 41.43M | 41.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |